- All sections
- C - Chemistrymetallurgy
- C07C - Acyclic or carbocyclic compounds
- C07C 279/06 - Derivatives of guanidine, i.e. compounds containing the group the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton being further substituted by halogen atoms, or by nitro or nitroso groups
Patent holdings for IPC class C07C 279/06
Total number of patents in this class: 29
10-year publication summary
|
5
|
5
|
5
|
4
|
1
|
0
|
2
|
1
|
1
|
2
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Lantheus Medical Imaging, Inc. | 177 |
7 |
| Immunomet Therapeutics Inc. | 31 |
5 |
| Molecular Insight Pharmaceuticals, Inc. | 56 |
4 |
| The Trustees of the University of Pennsylvania | 4323 |
2 |
| JPMorgan Chase Bank, National Association | 8565 |
2 |
| NUtech Ventures | 337 |
2 |
| The Regents of the University of Michigan | 4711 |
1 |
| The Johns Hopkins University | 5675 |
1 |
| Duke University | 3069 |
1 |
| University of South Florida | 1834 |
1 |
| Alzchem Trostberg GmbH | 264 |
1 |
| Regents of the University of Minnesota | 2693 |
1 |
| University of Strathclyde | 220 |
1 |
| Other owners | 0 |